Sarepta Therapeutics | SRPT - Zahlungsmittel Und Äquivalente

Aktienkurs
20.30
Täglich Wechseln
-0.12 -0.59%
Monatlich
-14.60%
Jährlich
-66.41%
Q2 Prognose
19.87




Zahlungsmittel Und Äquivalente Veränderung Datum
Acadia Pharmaceuticals USD 819.69M 27.33M 2025-12
Agios Pharmaceuticals USD 89.13M 3.58M 2025-12
Alnylam Pharmaceuticals USD 1.66B 167M 2025-12
Amgen USD 9.13B 316M 2025-12
BioCryst Pharmaceuticals USD 335.91M 251.83M 2025-12
Biogen USD 3.01B 854.3M 2025-12
BioMarin Pharmaceutical USD 1.31B 61.57M 2025-12
Capricor Therapeutics USD 287.85M 268.34M 2025-12
Daiichi Sankyo JPY 542.16B 97.68B 2025-09
Eli Lilly USD 7.27B 2.52B 2025-12
Esperion Therapeutics USD 92.45M 6.39M 2025-09
Gilead Sciences USD 7.56B 234M 2025-12
Incyte USD 3.58B 650.78M 2025-12
Insmed USD 510.44M 175.68M 2025-12
Ionis Pharmaceuticals USD 2.68B 437M 2025-12
Moderna USD 2.6B 1.46B 2025-12
Nektar Therapeutics USD 15.12M 25.92M 2025-12
Neurocrine Biosciences USD 713M 372.8M 2025-12
Novavax USD 240.63M 27.39M 2025-12
Pfizer USD 1.34B 295M 2025-09
PTC Therapeutics USD 984.65M 312.03M 2025-12
Regeneron Pharmaceuticals USD 18.87B 16.36B 2025-12
Roche Holding CHF 7.55B 579M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
Sarepta Therapeutics USD 801.28M 188.2M 2025-12
Tectonic Therapeutic USD 253.8M 14.64M 2025-12
Ultragenyx Pharmaceutical USD 202.51M 36.4M 2025-09
Vertex Pharmaceuticals USD 6.61B 321.1M 2025-12